The monoclonal antibodies in veterinary health market face growth opportunities due to rising animal chronic diseases and pet ...
Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”) a clinical-stage biotechnology company focused on unlocking new therapeutic ...
Researchers have identified a promising new weapon against triple-negative breast cancer, one of the most aggressive forms of ...
America has an Alzheimer’s problem, devastating families and driving soaring healthcare costs. More than 7 million people over 65 years old live with Alzheimer’s dementia today, a number predicted to ...
More than half of patients in a Phase III clinical trial who received a limited course of the experimental monoclonal ...
Learn how pH-sensitive dye detection supports reliable ADC internalization assays and insight into cellular uptake mechanisms ...
To this day, animal testing remains one of the most controversial issues in animal rights. Activists have been fighting ...
Rising biotech investments and demand for therapeutic proteins are fueling rapid growth in protein expression systems, with ...
Berger has participated in meetings (lectures, advisory boards, consultations) sponsored and compensated by pharmaceutical ...
Novartis NVS announced that the FDA granted Breakthrough Therapy designation to its pipeline candidate, ianalumab for the treatment of adult patients with Sjogren’s disease — a chronic, systemic ...
The panel discussion, “Innovations in Breast Cancer Treatment,” examined the challenge of maintaining or increasing access to care as breast cancer treatment becomes more stratified through biomarker ...
TOKYO -- The leader of Japanese opposition party Reiwa Shinsengumi, Taro Yamamoto, 51, announced on the party's YouTube ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results